These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24178903)

  • 1. Deliberate fingolimod overdose presenting with delayed hypotension and bradycardia responsive to atropine.
    Stephenson M; Wong A; Rotella JA; Crump N; Kerr F; Greene SL
    J Med Toxicol; 2014 Jun; 10(2):215-8. PubMed ID: 24178903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zigadenus poisoning treated with atropine and dopamine.
    West P; Horowitz BZ
    J Med Toxicol; 2009 Dec; 5(4):214-7. PubMed ID: 19876855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged and symptomatic bradycardia following a single dose of fingolimod.
    Faber H; Fischer HJ; Weber F
    Mult Scler; 2013 Jan; 19(1):126-8. PubMed ID: 22729989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute on Chronic Ivabradine Overdose: a Case Report.
    Maskell K; Tse A; Wolf CE; Troendle M
    J Med Toxicol; 2016 Jun; 12(2):189-91. PubMed ID: 26856350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ability of atropine to prevent and reverse the negative chronotropic effect of fingolimod in healthy subjects.
    Kovarik JM; Slade A; Riviere GJ; Neddermann D; Maton S; Hunt TL; Schmouder RL
    Br J Clin Pharmacol; 2008 Aug; 66(2):199-206. PubMed ID: 18507656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atropine in the treatment of baclofen overdose.
    Cohen MB; Gailey RA; McCoy GC
    Am J Emerg Med; 1986 Nov; 4(6):552-3. PubMed ID: 3778604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed fingolimod-associated asystole.
    Espinosa PS; Berger JR
    Mult Scler; 2011 Nov; 17(11):1387-9. PubMed ID: 21652609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bradycardia and hypotension in mianserin intoxication.
    Koseoglu Z; Kara B; Satar S
    Hum Exp Toxicol; 2010 Oct; 29(10):887-8. PubMed ID: 20203131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute myocardial infarction complicated by hemodynamically unstable bradyarrhythmia: prehospital and ED treatment with atropine.
    Swart G; Brady WJ; DeBehnke DJ; MA OJ; Aufderheide TP
    Am J Emerg Med; 1999 Nov; 17(7):647-52. PubMed ID: 10597081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The real-life experience with cardiovascular complications in the first dose of fingolimod for multiple sclerosis.
    Fragoso YD; Arruda CC; Arruda WO; Brooks JB; Damasceno A; Damasceno CA; Finkelsztejn A; Finkelsztejn J; Gama PD; Giacomo MC; Gomes S; Goncalves MV; Matta AP; de Morais MM; Oliveira EM; Ribeiro Y; Sato HK; Tauil CB
    Arq Neuropsiquiatr; 2014 Sep; 72(9):712-4. PubMed ID: 25252236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fingolimod: a review of its use in the management of relapsing-remitting multiple sclerosis.
    Scott LJ
    CNS Drugs; 2011 Aug; 25(8):673-98. PubMed ID: 21790210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular toxicity with levetiracetam overdose.
    Page CB; Mostafa A; Saiao A; Grice JE; Roberts MS; Isbister GK
    Clin Toxicol (Phila); 2016; 54(2):152-4. PubMed ID: 26795744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed cardiac dysrhythmias after fingolimod administration.
    Rosini JM; Rajasimhan S; Fellows SE; Nomura JT
    Am J Emerg Med; 2015 Jul; 33(7):987.e1-3. PubMed ID: 25669873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study.
    Gold R; Comi G; Palace J; Siever A; Gottschalk R; Bijarnia M; von Rosenstiel P; Tomic D; Kappos L;
    J Neurol; 2014 Feb; 261(2):267-76. PubMed ID: 24221641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial.
    Laroni A; Brogi D; Morra VB; Guidi L; Pozzilli C; Comi G; Lugaresi A; Turrini R; Raimondi D; Uccelli A; Mancardi GL;
    BMC Neurol; 2014 Apr; 14():65. PubMed ID: 24690227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of the cardiovascular effects of fingolimod treatment in multiple sclerosis].
    Széplaki G; Merkely B
    Ideggyogy Sz; 2012 Nov; 65(11-12):369-76. PubMed ID: 23289171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy.
    Groves A; Kihara Y; Chun J
    J Neurol Sci; 2013 May; 328(1-2):9-18. PubMed ID: 23518370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bradycardia-hypotension syndrome in acute myocardial infarction. Reappraisal of the overdrive effects of atropine.
    Chadda KD; Lichstein E; Gupta PK; Choy R
    Am J Med; 1975 Aug; 59(2):158-64. PubMed ID: 1155475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult clonidine overdose: prolonged bradycardia and central nervous system depression, but not severe toxicity.
    Isbister GK; Heppell SP; Page CB; Ryan NM
    Clin Toxicol (Phila); 2017 Mar; 55(3):187-192. PubMed ID: 28107093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral fingolimod for the treatment of patients with relapsing forms of multiple sclerosis.
    Singer B; Ross AP; Tobias K
    Int J Clin Pract; 2011 Aug; 65(8):887-95. PubMed ID: 21679286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.